🧬 Product Description

Alluvi BPC-157 & TB-500 40mg (R&D Only) is a premium-grade research peptide blend developed for controlled laboratory and scientific investigation. This dual-compound formulation combines two of the most widely studied experimental peptides—BPC-157 and TB-500—into a single, stable 40mg research solution.

In modern peptide research, both compounds are frequently examined for their roles in cellular communication, tissue modelling, and regenerative pathway studies. When combined, they allow researchers to explore synergistic interactions in controlled experimental environments.

This product is strictly supplied for R&D and laboratory use only and is not intended for human or veterinary consumption.

---

🔑 Key Features

• Dual-peptide research blend: BPC-157 + TB-500
• Total strength: 40mg per vial
• Designed for laboratory R&D studies only
• High-purity, controlled synthesis formulation
• Stable peptide structure for research consistency
• Supports experimental regenerative pathway research
• UK-focused supply chain availability
• Sterile, sealed laboratory-grade packaging

---

🧪 Ingredients / Composition

• BPC-157 (20mg)
• TB-500 (20mg)
• Sterile research-grade stabilising medium (non-active)

---

⚙️ Research Applications (Laboratory Use Only)

This peptide blend is commonly explored in preclinical and biochemical research settings for:

• Tissue repair modelling
• Cellular regeneration pathways
• Angiogenesis and vascular response studies
• Muscle and connective tissue research
• Inflammatory response analysis
• Peptide interaction and synergy testing

Recent scientific discussions highlight that both peptides remain largely preclinical, with most evidence derived from cell and animal models rather than human trials, making them strictly experimental compounds.

---

💡 Benefits in Research Context

While not approved for medical use, researchers investigate potential mechanisms such as:

• Enhanced cellular signalling activity
• Improved tissue repair modelling in vitro
• Increased vascular response in experimental systems
• Synergistic peptide interaction analysis
• Regenerative pathway simulation studies

---

📦 Recommended Usage (R&D Guidelines)

For laboratory research only:

• Store at 2–8°C (refrigerated conditions)
• Avoid freezing or heat exposure
• Maintain sterile handling protocols
• Reconstitute only under controlled lab conditions
• Follow institutional research guidelines

---

🔗 Stacking & Combination Research

In experimental peptide studies, BPC-157 & TB-500 is sometimes evaluated alongside:

• Other regenerative research peptides
• Growth factor studies
• Cellular repair compounds
• Experimental inflammation pathway models

These combinations are used purely for mechanistic and biochemical research purposes, not therapeutic use.

---

⚠️ Safety & Precautions

• Strictly R&D ONLY – not for human or animal use
• Not approved as a medicine in the UK
• Experimental compound with limited human clinical data
• Potential risks include unknown toxicity, purity variability, and regulatory restrictions
• Handle only in certified laboratory environments
• Follow all local MHRA and institutional compliance rules

UK regulators have emphasized that peptides marketed for research may still fall under medicinal regulations if misused or misrepresented.